Coherus BioSciences
Price & Volume
Stats
See more52W Range | $0.66-$2.43 |
Market Cap | $95.4M |
Shares Short | 31M |
Financials
See moreRevenue (12 Mos) | $272.2M |
Revenue Growth (YoY) | -0.4% |
Gross Profit (12 Mos) | $151.8M |
Diluted EPS | $0.44 |
News
See moreYahoo Finance • 5 days ago
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 12 days ago
Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
Yahoo Finance • last month
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
Yahoo Finance • 10 months ago
Coherus BioSciences, Inc. (CHRS): Worst 52-Week Low Stock to Buy Now
About
CEO | Mr. Dennis M. Lanfear |
Address | 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 228 |
